Age, Biography and Wiki
Geoffrey von Maltzahn is an American entrepreneur and venture capitalist. He is the co-founder and managing partner of the venture capital firm, Lux Capital. He is also the co-founder of the biotechnology company, Ginkgo Bioworks. Geoffrey von Maltzahn was born on 22 July, 1980 in American. He is currently 43 years old. Geoffrey von Maltzahn is 6 feet tall and weighs around 80 kgs. Geoffrey von Maltzahn is not known to be dating anyone currently. Geoffrey von Maltzahn is the son of German-born parents. Geoffrey von Maltzahn is a successful entrepreneur and venture capitalist. He is the co-founder and managing partner of the venture capital firm, Lux Capital. He is also the co-founder of the biotechnology company, Ginkgo Bioworks. He has invested in a number of companies, including Impossible Foods, Planet Labs, and Helion Energy. As of 2021, Geoffrey von Maltzahn's net worth is estimated to be around $200 million. He has earned most of his wealth from his successful career as an entrepreneur and venture capitalist.
| Popular As | N/A |
| Occupation | N/A |
| Age | 43 years old |
| Zodiac Sign | Cancer |
| Born | 22 July, 1980 |
| Birthday | 22 July |
| Birthplace | N/A |
| Nationality | American |
We recommend you to check the complete list of Famous People born on 22 July. He is a member of famous with the age 43 years old group.
Geoffrey von Maltzahn Height, Weight & Measurements
At 43 years old, Geoffrey von Maltzahn height not available right now. We will update Geoffrey von Maltzahn's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status | |
|---|---|
| Height | Not Available |
| Weight | Not Available |
| Body Measurements | Not Available |
| Eye Color | Not Available |
| Hair Color | Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
| Family | |
|---|---|
| Parents | Not Available |
| Wife | Not Available |
| Sibling | Not Available |
| Children | Not Available |
Geoffrey von Maltzahn Net Worth
His net worth has been growing significantly in 2022-2023. So, how much is Geoffrey von Maltzahn worth at the age of 43 years old? Geoffrey von Maltzahn’s income source is mostly from being a successful . He is from American. We have estimated Geoffrey von Maltzahn's net worth , money, salary, income, and assets.
| Net Worth in 2023 | $1 Million - $5 Million |
| Salary in 2023 | Under Review |
| Net Worth in 2022 | Pending |
| Salary in 2022 | Under Review |
| House | Not Available |
| Cars | Not Available |
| Source of Income |
Geoffrey von Maltzahn Social Network
Timeline
In 2009, Geoffrey von Maltzahn joined Flagship Pioneering, where he focuses on inventing and building new life science companies. In the same year, he co-founded Axcella Health, a company focused on developing amino acid therapeutics. In 2010, he co-founded Seres Therapeutics and served as the Chief Technology Officer. In 2013, he co-founded Indigo Agriculture, a company focused on improving the microbiome of modern crops and is currently Chief Innovation Officer. In 2015, he founded Kaleido Biosciences, is a clinical-stage biotechnology company engaged in the development of the microbiome. Until 2017, he served as the CEO of the company.
Geoffrey von Maltzahn was born in Arlington, Texas, and subsequently moved to Alexandria, Virginia where he graduated from Thomas Jefferson H.S. for Science and Technology. He was awarded his S.B. in Chemical Engineering from the Massachusetts Institute of Technology (MIT) in 2003, his Master of Science degree in Bioengineering from the University of California, San Diego in 2005, and his PhD from the Harvard–MIT Division of Health Sciences and Technology at the Massachusetts Institute of Technology in 2010.
Geoffrey von Maltzahn, Ph.D. (born July 22, 1980) is an American biological engineer and entrepreneur in biotechnology and life sciences industry who has founded a number of companies including Indigo Agriculture, Kaleido Biosciences, Seres Therapeutics, Axcella Health and Sienna Biopharmaceuticals. He is an inventor with 200 bioengineering and biotechnology patents and applications while has co-authored more than 20 peer-reviewed publications. He is a partner at Flagship Pioneering, a Massachusetts-based firm that funds start-ups in the healthcare and agriculture industries.
